NASDAQ:AHCO - Nasdaq - US00653Q1022 - Common Stock
The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81.
AHCO stock results show that AdaptHealth beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.